Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
35.65
+0.58 (1.65%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $516.41 million as of October 3, 2025. Its market cap has increased by 109.97% in one year.
Market Cap
516.41M
Enterprise Value
436.63M
1-Year Change
109.97%
Ranking
Category
Stock Price
$35.65
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $516.41M, an increase of 160.50%. That is a compound annual growth rate of 103.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 516.41M | 131.65% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |